DCE-MRI may be a prognostic biomarker for some tumors including osteosarcoma. The purpose of this study was to assess whether a DCE-MRI kinetic parameter map of osteosarcoma can provide prognostic indicators for clinical results using three deep convolution neural networks (DCNN). In this study, we found that DCNNs can provide biomarkers for overall survivals with accuracy over 0.8; three DCNNs have the comparable performance in prediction of clinical results; and the predictions using DCNN with tumor mask were significantly better than those without using tumor mask.
This abstract and the presentation materials are available to members only; a login is required.